2.7  0.15 (5.88%)		10-14 16:00
Open: 2.54 High: 2.73 Volume: 27,022		Pre. Close: 2.55 Low: 2.4513 Market Cap: 541(M)

Short term
Mid term
Targets	6-month :	3.58	1-year :	4.05
Resists	First :	3.07	Second :	3.47
Pivot price	2.76
Supports	First :	2.43	Second :	2.02
MAs	MA(5) :	2.61	MA(20) :	2.88
	MA(100) :	3.48	MA(250) :	4.63
MACD	MACD :	-0.2	Signal :	-0.2
%K %D	K(14,3) :	17.6	D(3) :	10.9
RSI	RSI(14): 36.6
52-week	High :	10	Low :	2.43

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ SSII ] has closed above bottom band by 38.8%. Bollinger Bands are 11.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	2.73 - 2.74	2.74 - 2.76
Low:	2.43 - 2.44	2.44 - 2.45
Close:	2.68 - 2.7	2.7 - 2.72

SS Innovations International, Inc., situated in Fort Lauderdale, Florida, focuses on the development of sophisticated robotic systems for surgical use. Their offerings encompass the SSI Mantra, a specialized surgical robot, and SSI Mudra, a suite of surgical instruments designed to facilitate various operations, including robotic cardiac surgery. The company also provides SSI Maya, a dedicated platform for robotic surgical interventions, along with OMNI 3D HD, which delivers a real-time, high-definition 3D perspective of the surgical field within the operating room.

Wed, 14 Oct 2026
SS Innovations International (SSII) Submits FDA Response for SSi Mantra Surgical Robotic System - NewMediaWire

Wed, 14 Oct 2026
SS Innovations International, Inc. (SSII) Files FDA 510(k) AI Response; Review Expected Q1 2027 - TradingView

Wed, 14 Oct 2026
SS Innovations International, Inc. (SSII) Submits FDA 510(k) RAI Response; Review Seen Q1 2027 - TradingView

Wed, 14 Oct 2026
SS Innovations International (NASDAQ: SSII) Submits FDA Response for SSi Mantra Surgical Robotic System - The Globe and Mail

Wed, 14 Oct 2026
symbol__ Stock Quote Price and Forecast - CNN

Tue, 13 Oct 2026
SS Innovations submits FDA response for surgical robot system - Investing.com

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Devices
Shares Out	200 (M)
Shares Float	41 (M)
Held by Insiders	80 (%)
Held by Institutions	0.8 (%)
Shares Short	68 (K)
Shares Short P.Month	73 (K)

EPS	-0.06
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0.27
Profit Margin	-23.8 %
Operating Margin	-16.3 %
Return on Assets (ttm)	-6.4 %
Return on Equity (ttm)	-26.1 %
Qtrly Rev. Growth	39.4 %
Gross Profit (p.s.)	0.12
Sales Per Share	0.26
EBITDA (p.s.)	-0.04
Qtrly Earnings Growth	0 %
Operating Cash Flow	-16 (M)
Levered Free Cash Flow	-4 (M)

PE Ratio	-45
PEG Ratio	0
Price to Book value	10
Price to Sales	10.3
Price to Cash Flow	-34.78

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.